GP data could reduce blood tests for methotrexate patients
Evidence from routinely collected patient data can be used to accurately predict who may experience side effects from methotrexate, the most commonly used immune-suppressing medicine in the UK, researchers have suggested. Using information that can be readily drawn from electronic health records and during routine consultations, the new findings could allow clinicians to decide how... Read moreThe post GP data could reduce blood tests for methotrexate patients appeared first on Nursing in Practice.
Source: Nursing in Practice - Category: Nursing Authors: Carolyn Scott Tags: Cancer Clinical Dermatology Source Type: news
More News: Cancer | Cancer & Oncology | Dermatology | Electronic Health Records (EHR) | Methotrexate | Nurses | Nursing | Skin